Real-time enrollment status for this prostate cancer clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 9:50 AM UTC
| NCT Number | NCT05946213 |
| Recruiting Status | Recruiting |
| Condition | Prostate Cancer |
| Phase | PHASE3 |
| Target Enrollment | 1,209 participants |
| Active Locations | 402 sites in the US |
| Sponsor | NRG Oncology |
| Last Updated on CT.gov | September 10, 2026 (Sep 10, 2026) |
As of October 16, 2026: Clinical trial NCT05946213 is currently recruiting participants. This phase3 study for prostate cancer is actively seeking new participants at 402 locations across the United States. The study is sponsored by NRG Oncology. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05946213 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 402 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05946213 was last updated Sep 10, 2026 (September 10, 2026). HelloStudys verifies this status automatically.